Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
A new nationwide cohort study has shown that patients with diabetes who use oral fluoroquinolone antibiotics are at greater risk for severe dysglycemia than those using other antibiotics.
And although the risk was low ? hyperglycemia or hypoglycemia related to fluoroquinolones occurred in fewer than 1 in 100 patients studied in the trial in 78,000 diabetics ? doctors should still exercise caution, say Hsu-Wen Chou, MD, PhD, from the National Taiwan University, Taipei, and colleagues in their paper published online August 15 in Clinical Infectious Diseases.
The risks also appear to vary according to the type of fluoroquinolone antibiotic used, and 1 in particular, moxifloxacin (Avelox, Bayer), appears to most increase the likelihood of hypoglycemia, an effect that is heightened among patients receiving concomitant insulin or sulfonylurea treatment, coauthor Wang Jiun-Lin, MD, from I-Shou University and E-Da Hospital, Kaohsiung, Taiwan, told Medscape Medical News.
http://www.medscape.com/viewarticle/809442
(free registration required)
And although the risk was low ? hyperglycemia or hypoglycemia related to fluoroquinolones occurred in fewer than 1 in 100 patients studied in the trial in 78,000 diabetics ? doctors should still exercise caution, say Hsu-Wen Chou, MD, PhD, from the National Taiwan University, Taipei, and colleagues in their paper published online August 15 in Clinical Infectious Diseases.
The risks also appear to vary according to the type of fluoroquinolone antibiotic used, and 1 in particular, moxifloxacin (Avelox, Bayer), appears to most increase the likelihood of hypoglycemia, an effect that is heightened among patients receiving concomitant insulin or sulfonylurea treatment, coauthor Wang Jiun-Lin, MD, from I-Shou University and E-Da Hospital, Kaohsiung, Taiwan, told Medscape Medical News.
http://www.medscape.com/viewarticle/809442
(free registration required)
